Schuerer Douglas J E, Kolovos Nikoleta S, Boyd Kayla V, Coopersmith Craig M
Department of Surgery, Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8109, St. Louis, MO 63110, USA.
Chest. 2008 Jul;134(1):179-84. doi: 10.1378/chest.07-2512.
Extracorporeal membrane oxygenation (ECMO) is a technique for providing life support for patients experiencing both pulmonary and cardiac failure by maintaining oxygenation and perfusion until native organ function is restored. ECMO is used routinely at many specialized hospitals for infants and less commonly for children with respiratory or cardiac failure from a variety of causes. Its usage is more controversial in adults, but select medical centers have reported favorable findings in patients with ARDS and other causes of severe pulmonary failure. ECMO is also rarely used as a rescue therapy in a small subset of adult patients with cardiac failure. This article will review the current uses and techniques of ECMO in the critical care setting as well as the evidence supporting its usage. In addition, current practice management related to coding and reimbursement for this intensive therapy will be discussed.
体外膜肺氧合(ECMO)是一种通过维持氧合和灌注,为同时患有肺衰竭和心力衰竭的患者提供生命支持的技术,直至其自身器官功能恢复。ECMO在许多专科医院被常规用于婴儿,较少用于因各种原因导致呼吸或心力衰竭的儿童。其在成人中的使用更具争议性,但一些特定的医疗中心报告称,在患有急性呼吸窘迫综合征(ARDS)和其他严重肺衰竭病因的患者中取得了良好效果。ECMO在一小部分成年心力衰竭患者中也很少用作抢救治疗。本文将回顾ECMO在重症监护环境中的当前用途和技术,以及支持其使用的证据。此外,还将讨论与这种强化治疗的编码和报销相关的当前实践管理。